Lisdexamfetamine Dimesylate
NDC 0527-4663, Lisdexamfetamine Dimesylate, capsule, from Lannett Company, LLC.
- Product NDC
- 0527-4663
- Status
- Listed
- Labeler
- Lannett Company, LLC
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA215802
- DEA schedule
- CII
curl https://api.healthcare.dev/v1/drugs/ndc/0527-4663 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LISDEXAMFETAMINE DIMESYLATE30 mg/1
Pharmacologic classes
Central Nervous System Stimulant [EPC]; Central Nervous System Stimulation [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0527-4663-37 | 00527466337 | 100 CAPSULE in 1 BOTTLE (0527-4663-37) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/2cedb4c2-1e40-4bc4-b9f4-127150c4afbdNADAC price for package 00527466337
GET /v1/drugs/nadac/00527466337
Use it
Look up 0527-4663 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0527-4663 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0527-4663. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.